NO994463D0 - Antitumor activity enhancement method of untreated drugs, composition containing untreated drug enhancement antitumor activity, evaluating method of antitumor efficacy of untreated drug therapy, and as - Google Patents

Antitumor activity enhancement method of untreated drugs, composition containing untreated drug enhancement antitumor activity, evaluating method of antitumor efficacy of untreated drug therapy, and as

Info

Publication number
NO994463D0
NO994463D0 NO994463A NO994463A NO994463D0 NO 994463 D0 NO994463 D0 NO 994463D0 NO 994463 A NO994463 A NO 994463A NO 994463 A NO994463 A NO 994463A NO 994463 D0 NO994463 D0 NO 994463D0
Authority
NO
Norway
Prior art keywords
untreated
enhancement
antitumor activity
antitumor
composition containing
Prior art date
Application number
NO994463A
Other languages
Norwegian (no)
Other versions
NO994463L (en
Inventor
Niwa Kozo
Original Assignee
Niwa Kozo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niwa Kozo filed Critical Niwa Kozo
Publication of NO994463D0 publication Critical patent/NO994463D0/en
Publication of NO994463L publication Critical patent/NO994463L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
NO994463A 1998-09-17 1999-09-15 Antitumor activity enhancement method of unprocessed natural remedies, composition containing unprocessed herbal enhancement antitumor activity, evaluation of method of antitumor efficacy in treatment with unprocessed herbal medicine NO994463L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (en) 1998-09-17 1998-11-13 Method of strengthening antitumor activity of crude drug, composition containing crude drug for strengthening antitumor activity, method of evaluating antitumor effectivity treated by crude drug and method of evaluating antitumor effectivity of crud drug

Publications (2)

Publication Number Publication Date
NO994463D0 true NO994463D0 (en) 1999-09-15
NO994463L NO994463L (en) 2000-03-20

Family

ID=26546176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994463A NO994463L (en) 1998-09-17 1999-09-15 Antitumor activity enhancement method of unprocessed natural remedies, composition containing unprocessed herbal enhancement antitumor activity, evaluation of method of antitumor efficacy in treatment with unprocessed herbal medicine

Country Status (19)

Country Link
JP (1) JP2000159682A (en)
KR (1) KR20000023206A (en)
CN (1) CN1255376A (en)
AU (1) AU4486299A (en)
BE (1) BE1012725A5 (en)
CA (1) CA2282234A1 (en)
DE (1) DE19944695A1 (en)
DK (1) DK199901235A (en)
ES (1) ES2155802B1 (en)
FR (2) FR2783426A1 (en)
GB (2) GB9920710D0 (en)
ID (1) ID23150A (en)
IL (1) IL131722A0 (en)
IS (1) IS5183A (en)
IT (1) IT1307267B1 (en)
NL (2) NL1013049C2 (en)
NO (1) NO994463L (en)
SE (2) SE9903307L (en)
SG (1) SG76631A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60218299T2 (en) * 2001-04-27 2007-10-31 Ajinomoto Co., Inc. A dispersion of beta-glucan-containing superfine particles, a corresponding manufacturing process and the use of the dispersion
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (en) * 2001-05-21 2010-07-14 コンビ株式会社 Composition for controlling pathogen infection
JP4561098B2 (en) * 2001-06-01 2010-10-13 味の素株式会社 Diabetes medicine
KR100971599B1 (en) 2002-05-15 2010-07-20 비에이취엔 가부시끼가이샤 Composition for Preventing or Treating Blood Vessel-Related Disease
JP4826696B2 (en) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 Angiogenesis inhibitors
JP4681801B2 (en) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 Angiogenesis inhibitor and method for producing the same
JP2005089417A (en) * 2003-09-19 2005-04-07 Noevir Co Ltd Composition for prevention/treatment of diabetes
JP4587441B2 (en) * 2004-02-12 2010-11-24 株式会社クレハ Novel diabetes treatment and food
JP5034071B2 (en) * 2004-09-17 2012-09-26 株式会社Ｓ・Ｓ・Ｉ Kawariharatake extract that suppresses breast cancer
JP2006273835A (en) * 2005-03-04 2006-10-12 Michishi Tani Therapeutic agent for malignant tumor and food or beverage containing the same
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
WO2011081024A1 (en) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 Umami food, and method for producing same
CN106309511A (en) * 2016-08-30 2017-01-11 青海民族大学 Effective part of agaricus gennadii for inhibiting CDC25 enzyme as well as preparation method and application of effective part
CN106333969A (en) * 2016-08-30 2017-01-18 青海民族大学 Agaricus gennadii HDAC1 enzyme inhibition effective part and preparation method and application
US20200397817A1 (en) * 2017-11-30 2020-12-24 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (en) * 2020-12-16 2024-03-12 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Grifola frondosa
KR102602787B1 (en) * 2020-12-16 2023-11-17 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Sparassis crispa
KR102584680B1 (en) * 2020-12-17 2023-10-06 대한민국 Method for manufacturing tea of Lentinula edodes tea improved physiological activities and nutrition components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (en) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (en) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd Food having antitumor function and production thereof
JP3357383B2 (en) * 1991-08-14 2002-12-16 昌宏 黒田 Low molecular weight plant composition
JP2955126B2 (en) * 1992-06-22 1999-10-04 笑代 丹羽 Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
ID23150A (en) 2000-03-23
NO994463L (en) 2000-03-20
ES2155802A1 (en) 2001-05-16
IS5183A (en) 2000-03-17
FR2783426A1 (en) 2000-03-24
SE0100195L (en) 2001-01-24
NL1019705C2 (en) 2002-03-26
GB9920710D0 (en) 1999-11-03
JP2000159682A (en) 2000-06-13
BE1012725A5 (en) 2001-02-06
NL1019705A1 (en) 2002-01-29
SE9903307D0 (en) 1999-09-16
SE9903307L (en) 2000-03-18
KR20000023206A (en) 2000-04-25
ITTO990784A0 (en) 1999-09-14
FR2788697A1 (en) 2000-07-28
CN1255376A (en) 2000-06-07
SG76631A1 (en) 2000-11-21
ITTO990784A1 (en) 2001-03-14
SE0100195D0 (en) 2001-01-24
GB9921387D0 (en) 1999-11-10
AU4486299A (en) 2000-03-30
GB2341800A (en) 2000-03-29
CA2282234A1 (en) 2000-03-17
DE19944695A1 (en) 2000-03-30
NL1013049C2 (en) 2002-01-11
NL1013049A1 (en) 2000-03-21
IT1307267B1 (en) 2001-10-30
ES2155802B1 (en) 2001-12-01
DK199901235A (en) 2000-03-18
IL131722A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
NO994463D0 (en) Antitumor activity enhancement method of untreated drugs, composition containing untreated drug enhancement antitumor activity, evaluating method of antitumor efficacy of untreated drug therapy, and as
WO2002056912A3 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
DE69929996D1 (en) PHARMACEUTICAL AGENT FOR THE TREATMENT OF DIABETES
IS6560A (en) Pharmaceutical composition for the treatment of acute, persistent pain and / or nervous system pain and migraine
WO2005027842A3 (en) Combinations of drugs for the treatment of neoplasms
DK0966454T3 (en) Disubstituted bicyclic heterocycles, their preparation and their use as drugs
WO2003090695A3 (en) TREATMENT OF α-GALACTOSIDASE A DEFICIENCY
EE200300369A (en) Acylated indanylamines, process for their preparation, use and pharmaceutical preparation
TR200100054T2 (en) Paroxetine methanesulfonate
PL349355A1 (en) Diaryl derivatives and their application as therapeutic agents
NO20010031D0 (en) Derivatives of 2-aminopyridines, their use as drugs and pharmaceutical preparations containing them
ID28028A (en) PHARMACEUTICAL SUBSTANCES FOR TREATMENT OF PARKINSON, ADHD AND MICROADENOMAS
PL341619A1 (en) Derivatives of cyclobutane, method of obtaining them and their therapeutic application
WO2005011572A3 (en) Combination of drugs for the treatment of neoplasms
UA32457C2 (en) Drug (variants) and methods for exposure to drug
NO20012428D0 (en) Substituted caprolactams, pharmaceutical compositions containing them and their use in the treatment of tumors
TR200402230T4 (en) O-substituted 6-methyl-tramadol derivatives
FR2845388B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
NO20006547L (en) Salts of paroxetine
PT1239862E (en) PHARMACEUTICAL PREPARATION CONTAINING CYTOSTATICS AND ELECTRO ACCEPTORS FOR THE TREATMENT OF CANCER
EE200300057A (en) Ingredients for the prevention and treatment of cancer
AU2003217697A8 (en) Prevention of and therapy for radiation toxicity of normal tissues using drugs which block il-1 activity
FR2772377B1 (en) DERIVATIVES OF 1- (1-H-IMIDAZOL-2-YL) PYRROLIDINES AND 1- (1-H-IMIDAZOL-2-YLPIPERIDINES), THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DE60233030D1 (en) TARTRATE AND PHOSPHATE SALT OF 3,4-DIAMINOPYRIDINE, PHARMACEUTICAL COMPOSITION AND ITS USE
ZA200100377B (en) Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method of assessing antitumor substance containing amygdalin.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application